TLR4 and rheumatoid arthritis: Although the role of TLR4 polymorphisms in CVDs have been inconsistent in the literature, recent reports have shown that the TLR4 rs4986790 polymorphism did not affect the risk of cardiovascular events in patients with rheumatoid arthritis (Chen, Gu, Gao, & Cen, 2015; Garcia‐Bermudez et al., 2012; Koch, Hoppmann, Pfeufer, Schomig, & Kastrati, 2006), which was consistent with our current results.